Created using Figma
Created using Figma
Software zum sicheren Speichern, Teilen und Schützen genomischer Daten
Risiko: Hoch
  • Market
    Volume 24H
    24H (price)
    24H (volume)
  • OKEx
    DNA/ETH 9 minutes ago
    $ 0.0238
  • OKEx
    DNA/USDT 9 minutes ago
    $ 0.0211
  • OKEx
    DNA/BTC 9 minutes ago
    $ 0.0299
  • Cryptopia
    DNA/BTC 6 hours ago
    $ 0.0189
    $ 6.9 K
  • ForkDelta
    DNA/ETH 21 hours ago
    $ 0.0113
  • Idex
    DNA/ETH one day ago
    $ 0.0175
  • Cryptopia
    DNA/LTC 17 days ago
    $ 0.0241
    $ 2.06
  • KuCoin
    DNA/ETH 26 days ago
    $ 0.0255
    $ 133.81
  • KuCoin
    DNA/BTC 26 days ago
    $ 0.0278
    $ 694.18
  • Everbloom
    DNA/ETH 27 days ago
    $ 0.0269
  • Cryptopia
100% completed
$1 254 595
100% ziel completed
Token Details
Company Details
Registered Country
United States
Additional Details
Kryptowährung, Software

Über Encrypgen

Gene-Chain Coin (DNA) is the medium of exchange for the Gene-Chain blockchain, described in our white paper and recent news articles including recently in Forbes. It is to be generated by nodes on the Gene-Chain and exchanged as the medium for transactions on the network. The number of total tokens will depend on the miners involved in the private network, as well as by the genomic data that will populate the Gene-Chain. Not all users of the Gene-Chain will mine at the same rates and some will not mine at all, so they will seek DNA on the crypto markets.

The total DNA supply will be 100,00,000. From them 10 mil are for Core Team, 5 mil for Marketing, 5 mil for bonuses and the rest 80 mil for sale. For our token sale we are offering 80,000,000 tokens and capping our offering at 1000 BTC realized in the crowdsale. For the first week, 1 BTC buys 80,000 Gene-Chain Coins. We are using a SAFT (Simple Agreement for Future Tokens) for the exchange as the tokens are to be mined as the Gene-Chain grows. The SAFT is a safe and legal, binding contract for the purchase of unmined tokens. Purchasers via the SAFT will receive their tokens in their wallets at the conclusion of our crowdfund of 1000BTC. Wallets will be available August 1, 2017 and DNA transferred first to ICO participants until remuneration is complete.

Procedure for the Token Sale:

Send any amount of BTC, ETH, Dash, LTC, or ETC to the addresses on this page and fill in the form you will find there. You will receive within 24 hours a signed SAFT agreement, and wallets will be distributed as soon as we reach our goal.

Beginning at 9 am ET June 1, 2017, Users can fill out a web form on the Gene-Chain page of the Encrypgen website indicating their Name, BTC address, and amount of BTC to be used for purchase.

Confirmation emails will be sent within 24 hours of each email received via the webform indicating customer # (beginning at #1), projected bonuses involved in the purchase, and total tokens to be credited to the purchaser for the purchase once completed. The SAFT will be attached indicating these figures and must be completed by the purchaser and signed. The customer will be given in that email the BTC address to which the transfer must be made.

Once Encrypgen receives the completed SAFT and confirmation of BTC received by Encrypgen, the SAFT will be countersigned and returned to the purchaser within 24 hours of receipt of BTC by Encrypgen. The purchase shall be considered complete upon receipt of BTC by Encrypgen for the purposes of the sale.

Tokens in wallets will be transferred to purchasers July 19, 2017

Bonuses: There are bonuses both for early purchases and size of investment

Early adopter bonus: each week the amount that 1 BTC buys deceases by 5% (except weeks 5-7), so: 1st week -> 80k, 2nd week -> 76k, 3rd week -> 72k, 4th week -> 68k, 5th week -> 64k, 6th week -> 60k

Purchases over 5 BTC will get 5% extra. Biggest purchase will get 1,000,000 extra Gene-Chain Coins. You can buy GCC with Bitcoin (BTC), Ethereum (ETH), Ethereum Classic (ETC), Dash (DASH) and Litecoin (LTC).

Encrypgen Roadmap

  • Mai 2017

  • Erfolgreiche Blockchain-Demo auf der Bio-IT Boston
  • Juli 2017

  • Abschlussvertrag für den Kauf von Knoten; derzeit laufende Gespräche mit mehreren interessierten Interessenten.
    Token-Verkauf abschließen
    Brieftaschen mit DNA-Tokens verteilen
  • August 2017

  • DNA-Tokens auf Krypto-Börsen
    Erweitern Sie Vertriebs- und PR-Team, um bei Bereitstellungen zu helfen. Entwicklerteam erweitern
    Vollständige Benutzeroberfläche für das Gene-Chain-Frontend bis Ende des Monats
  • 2018

  • Starten Sie das Social Media Portal und laden Sie die Seite für einzelne genomische Daten als kostenlosen Service hoch
    Integrieren Sie geo-lokal geeignete Genehmigungsverfahren für die Teilnahme an der Studie.


1 661
2 021
1 882
5 256
2 729
30 Days Growth:

1 832 068
39 085


Verifiziert 0%

Beachtung. Es besteht das Risiko, dass nicht verifizierte Mitglieder nicht Mitglieder des Teams sind

Gianfranco Tavella
Software engineer


Verifiziert 0%

Beachtung. Es besteht das Risiko, dass nicht verifizierte Mitglieder nicht Mitglieder des Teams sind

Vanessa Gonzalez Cov...
Co founder & Genomic science advisor

Last News

$ 0.0189
Coin Stats
Daily, %:
Weekly, %:
Monthly, %:
Market Info
Market Cap:
$ 822.492 K
Volume 24h:
Circ. Supply:
43.62 M DNA
5.0 16
ICO-Profil Vision Aktivität Potenzial Produkt Mannschaft

Encrypgen Reviews

Encrypgen is a unique blockchain technology specifically targeted at the world of genetic research. It plans to make it easier for patients to manage their genetic data. Patients can use Encrypgen’s core platform, the Gene-Chain, to control access to their genetic data. They can choose to share certain genetic data with researchers, for example, or show parts of the genome to medical professionals on request. We live in a world where more and more people are getting genetic tests – but nobody really knows how to manage all of this data. Encrypgen’s Gene-Chain wants to solve that problem.
  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us.
Bitte lesen Sie den Haftungsausschluss und die Risikowarnung. Zeige Disclaimer und Risikowarnung.
Planning an ICO? We can help with a wide range of support for all stages of your ICO